Literature DB >> 28684242

[Hypofractionated stereotactic body radiation therapy for adrenal metastases].

G Dupic1, J Biau2, A Bellière-Calandry2, M Lapeyre2.   

Abstract

Adrenal glands are a common site for metastatic spread since they represent the fourth metastatic site of solid tumors. Interest in local ablative treatments of oligometastases is growing since literature suggests better progression-free survival, quality of life and potentially overall survival in selected patients. Surgery remains the first treatment of adrenal oligometastases because results are good, with a long enough follow-up. However, stereotactic radiotherapy appears to be comparable to surgery and could be proposed to elderly, unfit, inoperable patients, or even to patients whose systemic treatment should not be suspended for too long. This article aims to present a review of published studies to date on stereotactic radiotherapy of adrenal metastases and to propose a treatment protocol.
Copyright © 2017 Société française de radiothérapie oncologique (SFRO). Published by Elsevier SAS. All rights reserved.

Entities:  

Keywords:  Adrenal glands; Dose; Efficacité; Efficacy; Hypofractionation; Hypofractionnement; Oligometastases; Oligométastases; Radiotherapy; Radiothérapie; Stereotactic; Stéréotaxie; Surrénales; Volume

Mesh:

Year:  2017        PMID: 28684242     DOI: 10.1016/j.canrad.2017.05.005

Source DB:  PubMed          Journal:  Cancer Radiother        ISSN: 1278-3218            Impact factor:   1.018


  1 in total

1.  ADVANCES IN RADIOTHERAPY OF ADRENAL GLAND LESIONS.

Authors:  X E Bacinschi; R M Anghel
Journal:  Acta Endocrinol (Buchar)       Date:  2022 Jan-Mar       Impact factor: 1.104

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.